Researchers Discover Biliary Cells Function as Active Guardians Against Fatal Liver Fibrosis

CNIO researchers identify a protein barrier in bile ducts that prevents liver scarring, explaining why some fibrosis drugs fail in specific patients.

By: AXL Media

Published: Apr 28, 2026, 10:30 AM EDT

Source: Information for this report was sourced from News-Medical.net

Redefining the Biological Role of Bile Ducts

For decades, the biliary system was viewed by the medical community as a series of passive conduits designed solely for the transport of bile. However, research published in Nature Metabolism on April 28, 2026, has upended this perspective, revealing that the cells lining these ducts are critical regulators of organ health. Nabil Djouder and his team at the CNIO Growth Factors, Nutrients and Cancer Group have demonstrated that biliary epithelial cells (BEC) act as active "guardians." These cells utilize complex signaling to maintain a sealed environment, ensuring that corrosive bile acids do not infiltrate the surrounding liver parenchyma and trigger a cascade of permanent damage.

The Molecular Shield of FXR and YAP Proteins

The study identifies a specific molecular machinery that allows the bile ducts to function as an impermeable barrier. Under healthy physiological conditions, a protein known as the FXR receptor operates within the BECs to detect the presence of bile acids. Once activated, FXR triggers the production of a second protein, YAP, which performs two essential tasks: it tightens the physical junctions between cells to prevent leaks and regulates cell division to prevent overgrowth. This dual action preserves the integrity of the ductal "pipes," effectively shielding the liver from the inflammatory triggers that lead to the accumulation of scar tissue, or fibrosis.

Mechanisms of Barrier Failure and Fibrosis

When the FXR-YAP signaling pathway is compromised due to genetic factors or disease, the protective barrier effectively dissolves. The CNIO researchers found that the absence of functional FXR causes biliary cells to proliferate uncontrollably while simultaneously weakening their physical bonds. This failure allows bile acids to seep into the liver tissue, where they activate stellate cells. These activated cells are the primary drivers of fibrosis, producing the stiff, scarred tissue that eventually leads to cirrhosis. By utilizing the first genetic mouse model for cirrhosis, the team proved that the loss of these receptors significantly accelerates the transition from localized scarring to total organ failure.